Table 5.

T/L measured for nine lung tumors as a function of the time elapsed after radiopharmaceutical administration. In bracket, we indicated the patient identifier

Time (min post-admin)	3	11	18	30	40	50	60
T1 (P1)	2.22	2.32	2.42	2.37	2.49	2.35	2.39
T2 (P3)	2.58	3.04	3.43	3.03	3.71	3.65	3.39
T3 (P3)	2.67	3.88	4.44	4.14	4.86	5.06	4.65
T4 (P4)	4.60	5.72	5.89	6.19	6.75	6.62	6.59
T5 (P4)	4.90	6.04	6.23	6.65	7.21	7.08	7.08
T6 (P5)	1.74	2.42	2.67	2.93	2.75	2.77	2.71
T7 (P5)	5.79	8.41	9.27	9.21	8.90	8.90	8.87
T8 (P5)	1.78	2.00	2.09	2.06	2.14	2.07	2.00
T9 (P6)	5.32	5.06	4.89	5.22	5.17	5.89	5.65
Average	3.51	4.32	4.59	4.65	4.89	4.93	4.81
SD	1.62	2.15	2.30	2.38	2.35	2.38	2.39